康希诺跌2.56% 2020年上市募52亿元中信证券保荐

Group 1 - The stock price of CanSino Biologics (688185.SH) fell by 2.56% to 62.84 yuan, indicating it is currently in a state of decline since its IPO [1] - CanSino was listed on the Shanghai Stock Exchange's STAR Market on August 13, 2020, with an initial issuance of 24.8 million shares at a price of 209.71 yuan per share [1] - The total funds raised from the IPO amounted to 5.201 billion yuan, with a net amount of 4.979 billion yuan after deducting issuance costs, which was 3.979 billion yuan more than the original plan of 1 billion yuan [1] Group 2 - The issuance costs for CanSino's IPO were 221 million yuan, with underwriting and sponsorship fees accounting for 205 million yuan [2] - CITIC Securities, as the lead underwriter, received an allocation of 496,000 shares, representing 2% of the total shares issued, with an investment amount of 104 million yuan [2]